RA Capital Management »

Palatin Technologies shares owned by RA Capital Management

Quarter-by-quarter ownership of Palatin Technologies (PTN) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Palatin Technologies

Tip: Access up to 7 years of quarterly data

All positions including Palatin Technologies held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palatin Technologies by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 70k 15.38

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Cidara Therapeutics SH (CDTX)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Vaxcyte SH (PCVX)
Sionna Therapeutics SH (SION)
Newamsterdam Pharma Co Nv SH (NAMS)
Tyra Biosciences SH (TYRA)
Wave Life Sciences SH (WVE)
Mineralys Therapeutics SH (MLYS)
Edgewise Therapeutics SH (EWTX)
Septerna SH (SEPN)
Nuvalent Inc-a SH (NUVL)
Disc Medicine SH (IRON)
Janux Therapeutics SH (JANX)

View all positions for RA Capital Management

Top funds holding Palatin Technologies

Driehaus Capital Management
Logos Global Management
Point72 Asset Management
RA Capital Management
Perceptive Advisors
Superstring Capital Management
Vanguard Group
Geode Capital Management
Millennium Management
Jane Street
Bleichroeder
UBS Group
Us Bancorp
BlackRock
Atlantic Trust

View all funds holding Palatin Technologies